Retrospective evaluation of prognostic factors in metastatic spine disease: serum albumin and primary tumour type are key.

Based on serum albumin and primary tumour type, we propose the 'Metastatic Spine Risk Index' as a simple and objective tool, specific to our population for predicting survival, which can be used in conjunction with other clinical information when considering treatment options.